3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review

3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH55989FSA
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

3SBio Inc (1530)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


3SBio Inc (3SBio) is a biotechnology companies that carries out the research, development, manufacturing and marketing of biopharmaceutical products. It develops recombinant, or genetically engineered, protein-based products and other pharmaceutical product candidates to address large markets with significant unmet medical needs in the areas of cancer and its supportive care, nephrology, dermatology and other therapeutic areas. the company's products are distributed to hospitals, clinics and dialysis centers across China. The company's products are approved for sale in Colombia, Brazil, Costa Rica, Egypt, Dominican Republic, Guatemala, El Salvador, Mongolia, Laos, Pakistan, Sri Lanka, Myanmar, Philippines, Paraguay, Thailand and Trinidad and Tobago. 3SBio is headquartered in Shenyang, China.

3SBio Inc Key Recent Developments

May 01,2018: Refuge Biotechnologies Completes USD 25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology

Jan 09,2017: 3SBio Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

3SBio Inc-Key Facts 5

3SBio Inc-Key Employees 6

3SBio Inc-Key Employee Biographies 7

3SBio Inc-Major Products and Services 8

3SBio Inc-History 10

3SBio Inc-Company Statement 13

3SBio Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

3SBio Inc-Business Description 16

R&D Overview 16

3SBio Inc-Corporate Strategy 17

3SBio Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

3SBio Inc-Strengths 18

3SBio Inc-Weaknesses 19

3SBio Inc-Opportunities 20

3SBio Inc-Threats 21

3SBio Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

3SBio Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

May 01, 2018: Refuge Biotechnologies Completes USD 25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology 33

Jan 09, 2017: 3SBio Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer 34

Section 6-Appendix 35

Methodology 35

Ratio Definitions 35

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

3SBio Inc, Performance Chart (2013-2017) 27

3SBio Inc, Ratio Charts 29

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

3SBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

List of Tables

3SBio Inc, Key Facts 5

3SBio Inc, Key Employees 6

3SBio Inc, Key Employee Biographies 7

3SBio Inc, Major Products and Services 8

3SBio Inc, History 10

3SBio Inc, Other Locations 14

3SBio Inc, Subsidiaries 14

3SBio Inc, Key Competitors 22

3SBio Inc, Ratios based on current share price 23

3SBio Inc, Annual Ratios 24

3SBio Inc, Annual Ratios (Cont...1) 25

3SBio Inc, Annual Ratios (Cont...2) 26

3SBio Inc, Interim Ratios 28

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

3SBio Inc, Recent Deals Summary 32

Currency Codes 35

Capital Market Ratios 35

Equity Ratios 36

Profitability Ratios 36

Cost Ratios 37

Liquidity Ratios 37

Leverage Ratios 38

Efficiency Ratios 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Shandong Kexing Bioproducts Co Ltd

Nanjing Hencer Pharmaceutical Co., Ltd.

Kirin Brewery Co Ltd

Hubei Guangji Pharmaceutical Co Ltd

Harbin Pharmaceutical Group Holding Co Ltd

China Intertrade Ltd

CapitalBio Corp

Beijing Novartis Pharma Co Ltd

3SBio Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8625
Site License
USD 250 INR 17250
Corporate User License
USD 375 INR 25875



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com